Locations:

Research

October 26, 2020/COVID-19

Thrombotic Events in Symptomatic COVID-19: New Data Suggest Potentially Attenuated Risk

Our early experience shows lower-than-reported incidence, hints at role for neutrophilia

October 22, 2020/COVID-19

Elevated CRP and LDH Predict Non-ICU Hospital Course for COVID-19

Findings from a 24/7 central monitoring unit yield insights for care outside pandemic epicenters

October 12, 2020/Heart, Vascular and Thoracic/Research

TAVR More Apt to Help Than Harm in CKD, PARTNER Subanalysis Shows

Findings offer reassurance, clarify understanding of cardiorenal syndrome

20-HVI-1951030 Takotsubo syndrome_650x450

September 15, 2020/Heart, Vascular and Thoracic/Research

Takotsubo Syndrome: New Insights on Echocardiographic and Clinical Prognostic Factors

Both LVEF and global longitudinal strain add prognostic value, study shows

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

20-HVI-1951031_cryoballoon-ablation-device_650x450

August 29, 2020/Heart, Vascular and Thoracic/Research

Cryoballoon Ablation Safe and Effective as First-Line Therapy for Paroxysmal Atrial Fibrillation

STOP AF First trial finds pulmonary vein isolation compares favorably to antiarrhythmic drugs

August 27, 2020/Heart, Vascular and Thoracic/Research

Extended Dual Antiplatelet Therapy After PCI With DES Curbs MI but Boosts Bleeding

Updated meta-analysis supports personalizing antiplatelet strategies

August 18, 2020/Heart, Vascular and Thoracic/Research

Post-Implant PDE5 Inhibitor Therapy Lowers Thrombotic Events in LVAD Patients

INTERMACS analysis sets the stage for a confirmatory randomized trial

August 6, 2020/COVID-19

Reigniting Clinical Research in the Wake of a Pandemic

Perspectives and learnings from our Heart, Vascular & Thoracic Institute

August 5, 2020/Heart, Vascular and Thoracic/Research

Stroke Reduction in TAVR Patients: Clearer Answers Are on the Horizon

Insights on the PROTECTED TAVR and WATCH-TAVR trials

July 31, 2020/Geriatrics

POEM for Achalasia: Safe and Highly Effective in Geriatric Patients

Review finds similar outcomes in elderly and young cohorts

BackPage 4 of 8Next